Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hanna Augustyniak-Bartosik

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Reumatologia|February 7, 2024
Rheumatoid arthritis - medication dosage in chronic kidney diseaseKinga Maria Tyczyńska, Hanna Augustyniak-Bartosik, Jerzy Świerkot
Postepy Higieny I Medycyny Doswiadczalnej (Online)|March 15, 2005
[Autosomal dominant polycystic kidney disease--research status and clinical manifestation]Hanna Augustyniak-Bartosik, Wacław Weyde, Magdalena Krajewska, et al.
Postepy Higieny I Medycyny Doswiadczalnej (Online)|June 24, 2016
Geriatric syndromes in patients with chronic kidney diseaseTomasz Gołębiowski, Hanna Augustyniak-Bartosik, Wacław Weyde, et al.
Polskie Archiwum Medycyny Wewnetrznej|May 15, 2014
Stratifying risk for progression in IgA nephropathy: how to predict the future?Agnieszka Rafalska, Jolanta Franczuk, Paweł Franczuk, et al.
Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University|February 23, 2022
Are in clinical practice measurements of concentrations and the calculation of mycophenolate mofetil pharmacokinetic parameters needed for optimizing therapy in patients with renal diseases or kidney transplantation?Magdalena Hurkacz, Hanna Augustyniak-Bartosik, Joanna Pondel, et al.
Postepy Higieny I Medycyny Doswiadczalnej (Online)|March 12, 2013
Novel PKD1 mutations - the effect on clinical phenotype of ADPKD patients in Lower SilesiaHanna Augustyniak-Bartosik, Magdalena Krajewska, Wacław Weyde, et al.
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego|May 23, 2017
[Measurements of vancomycin concentrations in the blood - a method of personalization the antibiotic therapy in patients with chronic kidney disease]Joanna Pondel, Piotr Krajewski, Natalia Królikowska, et al.
Scientific Reports|January 27, 2026
Characteristics of motor polyneuropathy in Fabry disease: a case-control studyMagdalena Koszewicz, Edyta Dziadkowiak, Mariusz Szydlo, et al.
European Journal of Clinical Pharmacology|November 16, 2018
Pharmacokinetics of free and total mycophenolic acid in adult lupus nephritis patients-implications for therapeutic drug monitoringPaulina Łuszczyńska, Tomasz Pawiński, Paweł K Kunicki, et al.
Cells|August 7, 2021
Immune Cells Profiling in ANCA-Associated Vasculitis Patients-Relation to Disease ActivityMarcelina Żabińska, Katarzyna Kościelska-Kasprzak, Joanna Krajewska, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Reumatologia|February 7, 2024
Rheumatoid arthritis - medication dosage in chronic kidney diseaseKinga Maria Tyczyńska, Hanna Augustyniak-Bartosik, Jerzy Świerkot
Postepy Higieny I Medycyny Doswiadczalnej (Online)|March 15, 2005
[Autosomal dominant polycystic kidney disease--research status and clinical manifestation]Hanna Augustyniak-Bartosik, Wacław Weyde, Magdalena Krajewska, et al.
Postepy Higieny I Medycyny Doswiadczalnej (Online)|June 24, 2016
Geriatric syndromes in patients with chronic kidney diseaseTomasz Gołębiowski, Hanna Augustyniak-Bartosik, Wacław Weyde, et al.
Polskie Archiwum Medycyny Wewnetrznej|May 15, 2014
Stratifying risk for progression in IgA nephropathy: how to predict the future?Agnieszka Rafalska, Jolanta Franczuk, Paweł Franczuk, et al.
Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University|February 23, 2022
Are in clinical practice measurements of concentrations and the calculation of mycophenolate mofetil pharmacokinetic parameters needed for optimizing therapy in patients with renal diseases or kidney transplantation?Magdalena Hurkacz, Hanna Augustyniak-Bartosik, Joanna Pondel, et al.
Postepy Higieny I Medycyny Doswiadczalnej (Online)|March 12, 2013
Novel PKD1 mutations - the effect on clinical phenotype of ADPKD patients in Lower SilesiaHanna Augustyniak-Bartosik, Magdalena Krajewska, Wacław Weyde, et al.
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego|May 23, 2017
[Measurements of vancomycin concentrations in the blood - a method of personalization the antibiotic therapy in patients with chronic kidney disease]Joanna Pondel, Piotr Krajewski, Natalia Królikowska, et al.
Scientific Reports|January 27, 2026
Characteristics of motor polyneuropathy in Fabry disease: a case-control studyMagdalena Koszewicz, Edyta Dziadkowiak, Mariusz Szydlo, et al.
European Journal of Clinical Pharmacology|November 16, 2018
Pharmacokinetics of free and total mycophenolic acid in adult lupus nephritis patients-implications for therapeutic drug monitoringPaulina Łuszczyńska, Tomasz Pawiński, Paweł K Kunicki, et al.
Cells|August 7, 2021
Immune Cells Profiling in ANCA-Associated Vasculitis Patients-Relation to Disease ActivityMarcelina Żabińska, Katarzyna Kościelska-Kasprzak, Joanna Krajewska, et al.
Pageof 4